Neurotropic flavivirus Japanese encephalitis virus (JEV) and West Nile virus (WNV) are amongst the leading causes of encephalitis. Using label-free quantitative proteomics, we identified proteins differentially expressed upon JEV (gp-3, RP9) or WNV (IS98) infection of human neuroblastoma cells. Data are available via ProteomeXchange with identifier PXD016805. Both viruses were associated with the up-regulation of immune response (IFIT1/3/5, ISG15, OAS, STAT1, IRF9) and the down-regulation of SSBP2 and PAM, involved in gene expression and in neuropeptide amidation respectively. Proteins associated to membranes, involved in extracellular matrix organization and collagen metabolism represented major clusters down-regulated by JEV and WNV. Moreover, transcription regulation and mRNA processing clusters were also heavily regulated by both viruses. The proteome of neuroblastoma cells infected by JEV or WNV was significantly modulated in the presence of mosquito saliva, but distinct patterns were associated to each virus. Mosquito saliva favored modulation of proteins associated with gene regulation in JEV infected neuroblastoma cells while modulation of proteins associated with protein maturation, signal transduction and ion transporters was found in WNV infected neuroblastoma cells.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7202638 | PMC |
| http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0232585 | PLOS |
Publication Analysis
Top Keywords
Similar Publications
The impact of Aureobasidium melanogenum cells and extracellular vesicles on human cell lines.
Sci Rep
January 2025
Department of Biology, Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.
Aureobasidium melanogenum is a black yeast-like fungus that occurs frequently both in nature and in domestic environments. It is becoming increasingly important as an opportunistic pathogen. Nevertheless, its effect on human cells has not yet been studied.
View Article and Find Full Text PDFDeveloping Cryptic ACTL6B as Novel TDP‐43 Loss of Function Biomarker.
Alzheimers Dement
December 2024
Johns Hopkins University School of Medicine, Baltimore, MD, USA
Background: The nuclear clearance and cytoplasmic aggregation of splicing repressor TAR DNA/RNA‐binding protein‐43 (TDP‐43) occur in approximately 50% of Alzheimer’s disease (AD) cases and about 45% of frontotemporal dementia (FTD). However, it is not clear how early such mechanism occurs in AD and FTD as there is no method of detecting TDP‐43 dysregulation in living individuals. Since the loss of nuclear TDP‐43 leads to cryptic exon inclusion, we propose that cryptic exon‐encoded peptides may be detected in patient biofluids as biomarkers of TDP‐43 loss of function.
View Article and Find Full Text PDFCOX‐2 as a potential blood based biomarker and a possible therapeutic target in Alzheimer’s Disease.
Alzheimers Dement
December 2024
All India Institute of Medical Sciences, AIIMS, New Delhi, Delhi, India
Background: Alzheimer’s disease (AD) is a progressive brain disorder which leads to gradual decline in memory, thinking, behaviour and social skills. The current scenario for drug development is based on neuro‐inflammation and oxidative stress. Amyloid‐β (Aβ) deposition, a major hallmark of the disease activates microglia leading to neuro‐inflammation and neuro‐degeneration induced by activation of COX‐2 via NFkB p50 in glioblastoma cells.
View Article and Find Full Text PDFVEGFR1‐mediated neuronal cell death following Aß1‐42 oligomers treatment‐ Implications in AD pathogenesis.
Alzheimers Dement
December 2024
Mayo Clinic, Jacksonville, FL, USA
Background: Recent transcriptome analysis has demonstrated increased expression of Vascular Endothelial Growth Factor receptor‐1 (VEGFR‐1/) and decreased expression of VEGFR‐2/ in AD brain. Increased expression of VEGFR‐1 and its ligand VEGFB were associated with a more rapid rate of cognitive decline, providing evidence of a potential link between aberrant VEGFR‐1 expression in AD pathogenesis. .
View Article and Find Full Text PDFAlterations in protein conformation assessed by FTIR in EVs from an AD mimicking model.
Alzheimers Dement
December 2024
Neurosciences and Signalling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro, Aveiro, Portugal
Background: Aβ peptide is a central player in Alzheimer’s disease (AD) pathogenesis, which once generated rapidly tends to aggregate, from oligomers to fibrils and finally deposits into senile plaques, one of the disease hallmarks. Extracellular vesicles (EVs) are secreted by all cell types and recognized as key intercellular communication mediators. In AD, it has been reported that EVs can carry Aβ and may potentially accelerate its aggregation, thus contributing to the seeding of the toxic peptide.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!